More specifically, in pancreatic cancer cells, deoxycytidine kinase (dCK) mRNA interacts with HuR encoding the enzyme that metabolizes and activates gemcitabine [29]. This evidence concerns the gene ELAVL1 and familial pancreatic carcinoma.